Scholarlink

Liquid biopsies (e.g., blood draws) offer a less invasive and non-localized alternative to tissue biopsies for monitoring the progression of metastatic breast cancer (mBCa). Immunofluoresence (IF) microscopy is a tool to image and analyze millions of blood cells in a patient sample. By detecting and genetically sequencing circulating tumor cells (CTCs) in the blood, personalized treatment plans are achievable for various cancer subtypes. However, CTCs are rare (about 1 in 2M), making manual CTC detection very difficult. In addition, clinicians rely on quantitative cellular biomarkers to manually classify CTCs. This requires prior tasks of cell detection, segmentation and feature extraction. To assist clinicians, we have developed a fully automated machine learning-based production-level pipeline to efficiently detect, segment and classify CTCs in multi-channel IF images. We achieve over \(99\%\) sensitivity and \(97\%\) specificity on 9,533 cells from 15 mBCa patients. Our pipeline has been successfully deployed on real mBCa patients, reducing a patient average of 14M detected cells to only 335 CTC candidates for manual review.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fully Automated CTC Detection, Segmentation and Classification for Multi-channel IF Imaging

  • 会议论文

  • 发表日期：

    2025年

查看全文
  • Evan Schwab,
  • Bharat Annaldas,
  • Nisha Ramesh,
  • Anna Lundberg,
  • Vishal Shelke,
  • Xinran Xu,
  • Cole Gilbertson,
  • Jiyun Byun,
  • Ernest T. Lam

摘要

Liquid biopsies (e.g., blood draws) offer a less invasive and non-localized alternative to tissue biopsies for monitoring the progression of metastatic breast cancer (mBCa). Immunofluoresence (IF) microscopy is a tool to image and analyze millions of blood cells in a patient sample. By detecting and genetically sequencing circulating tumor cells (CTCs) in the blood, personalized treatment plans are achievable for various cancer subtypes. However, CTCs are rare (about 1 in 2M), making manual CTC detection very difficult. In addition, clinicians rely on quantitative cellular biomarkers to manually classify CTCs. This requires prior tasks of cell detection, segmentation and feature extraction. To assist clinicians, we have developed a fully automated machine learning-based production-level pipeline to efficiently detect, segment and classify CTCs in multi-channel IF images. We achieve over \(99\%\) sensitivity and \(97\%\) specificity on 9,533 cells from 15 mBCa patients. Our pipeline has been successfully deployed on real mBCa patients, reducing a patient average of 14M detected cells to only 335 CTC candidates for manual review.